Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Relay Therapeutics Inc (RLAY)

Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Relay Therapeutics Inc 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 USA

www.relaytx.com Employees: 323 P: 617-370-8837

Description:

Relay Therapeutics Inc. is a clinical-stage precision medicines company. It focuses on enhancing small molecule therapeutic discovery in targeted oncology. The company's product pipeline consist RLY-1971, RLY-4008 and RLY-PI3K1047 which are in clinical stage. Relay Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 696,313
Enterprise Value, $K 552,573
Shares Outstanding, K 167,383
Annual Sales, $ 25,550 K
Annual Net Income, $ -341,970 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -92,210 K
EBIT, $ -356,900 K
EBITDA, $ -362,390 K
60-Month Beta 1.59
% of Insider Shareholders 4.32%
% of Institutional Shareholders 96.98%
Float, K 160,152
% Float 95.68%
Short Volume Ratio 0.41

Growth:

1-Year Return -60.42%
3-Year Return -87.54%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.63 on 11/06/24
Next Earnings Date N/A
Earnings Per Share ttm -2.52
EPS Growth vs. Prev Qtr 8.70%
EPS Growth vs. Prev Year -16.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RLAY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -45.75%
Return-on-Assets % -40.75%
Profit Margin % -1,338.43%
Debt/Equity 0.00
Price/Sales 27.91
Price/Cash Flow N/A
Price/Book 0.85
Book Value/Share 5.14
Interest Coverage -3.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar